oncnursingnews7h
Managing Chemo-Induced Peripheral Neuropathy in Breast Cancer
BC, CNM, RNFA, spoke about the oncology nurse’s and APP’s roles in managing chemotherapy-induced peripheral neuropathy in ...
oncnursingnews11h
Telotristat Ethyl Plus Chemo May Stabilize Weight in Metastatic PDAC
Managing weight loss with telotristat ethyl in patients with metastatic pancreatic ductal adenocarcinoma may improve survival, although further research is needed.
oncnursingnews1d
Katie Goodman, RN, BSN, CCRP
ctDNA Status May Be Prognostic for DFS With Celecoxib for Stage III Resected Colon Cancer ...
oncnursingnews1d
FDA Approves T-DXd for Previously Treated HER2-Low and -Ultralow Metastatic Breast Cancer
T-DXd has received FDA approval for the treatment of unresectable or metastatic HR+, HER2-low/-ultralow breast cancer in ...
oncnursingnews1d
Telephone Follow-Ups May Reduce AEs in Locally Advanced ESCC
Phone calls to follow up with patients with locally advanced esophageal squamous cell carcinoma while at home may reduce AEs ...
oncnursingnews2d
Bernardo L. Rapoport, MD
ctDNA Status May Be Prognostic for DFS With Celecoxib for Stage III Resected Colon Cancer ...
oncnursingnews3d
Paige Soleimani, LMSW
ctDNA Status May Be Prognostic for DFS With Celecoxib for Stage III Resected Colon Cancer ...
oncnursingnews3d
Bevacizumab’s Benefit in Colorectal Cancer May Be Limited to 2 Years Post-Administration
The 2-year benefit of bevacizumab in colorectal cancer may explain why survival benefits are seen in studies with two-year, ...
oncnursingnews3d
Aspirin Linked to Lower CRC Recurrence in Patients With PI3K Mutations
Aspirin reduced disease recurrence in patients PI3K-mutated colorectal cancer, underscoring the value of early genomic ...
oncnursingnews4d
Susan Weiss Behrend, RN, MSN, AOCN
Preoperative Sintilimab with Chemoradiotherapy Boosts Response Rates in Resectable Esophageal Cancer 22% of Community Providers Reported Biomarker Testing in Gastric/GEJ Cancers ...